Initial ratings of different types of e-cigarettes and relationships between product appeal and nicotine delivery by Hajek, Peter et al.
ORIGINAL INVESTIGATION
Initial ratings of different types of e-cigarettes and relationships
between product appeal and nicotine delivery
Peter Hajek1 & Dunja Przulj1 & Anna Phillips-Waller1 & Rebecca Anderson1 & Hayden McRobbie1
Received: 20 October 2017 /Accepted: 27 December 2017 /Published online: 6 January 2018
# The Author(s) 2018. This article is an open access publication
Abstract
Aims Little is known about features of e-cigarettes (EC) that facilitate or hinder the switch from smoking to vaping. We tested
eight brands of EC to determine how nicotine delivery and other product characteristics influence user’s initial reactions.
Methods Fifteen vapers tested each product after overnight abstinence from both smoking and vaping. At each session, partic-
ipant’s vaped ad lib for 5 min. Blood samples were taken at baseline and at 2, 4, 6, 8, 10 and 30 min after starting vaping.
Participants rated the products on a range of characteristics. The products tested included six ‘cig-a-like’ and two refillable
products, one with variable voltage. We also tested participants’ own EC.
Results All products significantly reduced urges to smoke. Refillable products delivered more nicotine and received
generally superior ratings in terms of craving relief, subjective nicotine delivery, throat hit and vapour production but
in overall ratings, they were joined by a cig-a-like, Blu. Participants puffed more on low nicotine delivery products.
Participants’ estimates of nicotine delivery from different EC were closely linked to ‘throat hit’. Nicotine delivery
was less important in the initial product ratings than draw resistance, mouthpiece comfort and effects on reducing
urge to smoke.
Conclusions All EC products reduced urges to smoke. Refillable products received generally more favourable ratings than ‘cig-a-
likes’with similar nicotine content. Perception of nicotine delivery was guided by throat sensations. Lower nicotine delivery was
associated with more frequent puffing. The first impressions of EC products are guided less by nicotine delivery than by sensory
signals.
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Introduction
E-cigarettes (EC) have the potential to generate a substantial
public health benefit if there is a switch from smoking to
vaping on a population scale (Hajek et al. 2014a; PHE 2015;
RCP 2016). EC technology is evolving and market forces are
steering product development to features that appeal to
smokers and increase the rate of adoption. This has been pri-
marily an evolutionary process with a number of innovations
not taking hold and others slowly spreading. Up to now, very
little formal evaluation exists to determine which EC charac-
teristics appeal to smokers and drive EC choice.
Nicotine delivery is likely to be among the key factors that
determines whether a smoker will continue to use a device
(Marynak et al. 2017), but other product features are likely
to play an important role, particularly during early experimen-
tation. These may include characteristics such as product ap-
pearance, ease of use, puff resistance, ‘throat hit’, vapour vol-
ume, mouthpiece comfort, handling characteristics and e-
liquid flavour and other constituents. The cost and product
marketing are likely to be important too.
Determinants of consumer choice were examined so far
primarily by means of consumer surveys. Although vapers
often start with self-contained ‘cig-a-like’ products that are
cheaper and easier to use, those who switch to vaping
completely typically progress to refillable EC, which are by
far the most popular product among regular vapers (ASH
2015; Cooper et al. 2016; Dawkins et al. 2013; Giovenco
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et al. 2014; Yingst et al. 2015) and more strongly associated
with complete cessation of smoking (Hitchman et al. 2015).
The likely reason is that refillable EC with stronger batteries
provide better nicotine delivery (Farsalinos et al. 2014; Hajek
et al. 2017). Nicotine-free EC are rarely used (Dawkins et al.
2013). Regarding flavours, individual preferences can change
and vary widely (Cooper et al. 2016; Dawkins et al. 2013;
Farsalinos et al. 2013) but flavours influence EC use acutely
(Litt et al. 2016). In the only laboratory study evaluating user
reactions that we are aware of, EC alleviated craving propor-
tionally to their nicotine content (0, 24 or 36 mg/ml) when
participants could not touch them (held in a clamp), but the
discrimination was lost when they were held in hand (Van
Heel et al. 2017).
Better knowledge of what drives consumer preferences
could help smokers faced with the wide range of different
EC products, inform the choice of EC brands for studies of
the potential of EC in smoking cessation and guide further
product development.
In the first study of this type, we tested eight common EC
brands, together with vapers’ own devices, to determine how
nicotine intake by users combined with various product char-
acteristics determine user’s initial reactions.
Methods
Design
This was a crossover study involving eight popular EC prod-
ucts plus participants’ own EC.
Participants
Fifteen healthy vapers who were willing to test a series of EC
products were recruited via UK on-line forums of EC users
and by word of mouth. Eleven were ‘dual users’ (smoking and
vaping concurrently) and four had stopped smoking
altogether.
Procedures
Participants were pre-screened over the phone and attended
the laboratory after overnight abstinence from both smoking
and vaping.
Dual users started with a session where they smoked a
cigarette of their usual brand which they brought with them.
All participants, dual users and participants who only vaped,
attended the next session where their own-brand EC was test-
ed, followed by sessions testing eight different EC brands, one
at a time, in the same order. Sessions were scheduled with at
least 3-day ‘wash out’ periods between them.
The sessions took place between 7:30 and 9:30 a.m., de-
pending on the participants’ availability, and took about
60 min.
Participants received £60 at the end of each session.
At each session, an intravenous line for blood sampling
was placed in the forearm and the baseline blood sample
was taken, after which participants were asked to smoke/
vape ad lib for 5 min. Further blood samples were taken at
2, 4, 6, 8, 10 and 30 min after starting smoking/vaping.
We reported a comparison of pharmacokinetic (PK) pro-
files of own brand cigarette and different EC products in the
11 dual users in a separate report (Hajek et al. 2017).This
study uses the full sample of 15 participants and focuses on
EC product ratings.
The project was approved by the National Research Ethics
Service Committee SE Coast (14/LO/0358). All participants
gave written informed consent.
Measures
Demographic and smoking history data, including Fagerstrom
Test of Cigarette Dependence based on smoking prior to
switching to vaping (FTCD; (Heatherton et al. 1991)) were
collected at baseline. Number of puffs taken was counted dur-
ing the 5-min vaping period. Urges to smoke were rated at
baseline and at 5, 10, 15 and 30 min, on a scale of 1 (‘no urge
at all’) to 10 (‘extreme urge’).
At the end of each session, participants were asked to rate
the product on a scale of 1 to 10 regarding the following: ‘Did
it relieve your urge to smoke?’ (not at all (1)—extremely well
(10)); ‘How quickly did any effect happen?’ (very slowly
(1)—extremely fast (10)); ‘Did you like the taste?’ (not at all
(1)—extremely (10)); ‘How much nicotine do you think it
delivered?’ (too little (1)—just right (5)—too much (10));
‘Was it pleasant to use?’ (not at all (1)—extremely (10));
‘How hard was it to draw smoke from it?’ (too easy (1)—just
right (5)—too hard (10)); ‘How comfortable was the mouth-
piece?’ (not at all (1)—extremely (10)); ‘How would you rate
the amount of vapour it produced?’ (too little (1)—just right
(5)—too much (10)); ‘Howwould you rate the Bhit^/Bscratch^
at the back of your throat it provided?’ (too little (1)—just
right (5)—too much (10)); ‘How likely would you be to rec-
ommend it to friends?’ (not at all (1)—extremely (10)).
Questions regarding vapour and throat hit were included at a
later date, so only 9 of the 15 participants completed them for
all the study products.
After the final testing session, participants ranked all nine
EC products, including their own brand, in order of prefer-
ence. Participants had the pictures of the products in front of
them during this rating to aid recall.
Blood samples were analysed at ABS Laboratories Ltd.,
BioPark, Broadwater Road, Welwyn Garden City,
Hertfordshire, UK. PK parameters included maximum
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nicotine concentration (Cmax), time to the maximum (Tmax)
and area under the curve (AUC0–> 30), a measure of total nic-
otine delivery over 30 min. All measures were corrected for
baseline values.
Study products
The following six 1st generation (cig-a-like) products
were tested: Gamucci (16 mg/ml nicotine, ‘original
taste’ [tobacco],) Blu (18 mg/ml nicotine, flavour ‘clas-
sic tobacco’), Vype (16.8 mg/ml, ‘classic tobacco fla-
vour’, regular), E-Lites (24 mg/ml nicotine, ‘original’
[tobacco]), Puritane (20 mg/ml, ‘original’ [tobacco])
and Vuse (4.8% nicotine, ‘original’ [tobacco]). The
cig-a-like products included the four EC marketed by
the tobacco industry (Blu—Imperial, Vype—BAT,
Puritane—Imperial Tobacco and Vuse—RJ Reynolds)
and two products produced by independent manufac-
turers and popular in the UK (Gamucci and E-Lites
(E-Lites were later acquired by Japan Tobacco)).
Although some of these products are produced in dif-
ferent flavours, we only used the tobacco flavoured
ones to minimise the problem potentially posed by in-
dividual differences in taste preferences.
We also tested one 2nd generation refillable ‘tank’ product,
a popular mid-range KangerTech EVOD produced by Kanger
Technology, and one 3rd generation product (a tank product
which allows variable power setting), Innokin iTaste MVP 2
produced by Innokin Technology, set to 4.8 V (range 3.3–
5.0 V). Both of these refillable products were used with the
same 20 mg/ml nicotine e-liquid (Vermillion River ‘classic
blend’ [tobacco]).
For products marketed at different strengths, nicotine
concentrations were selected to be as close as possible
to 20 mg/ml. Across products tested, the e-liquids
contained 16–20 mg/ml of nicotine, with two excep-
tions. We used E-Lites with 24 mg/ml of nicotine to
assess a cig-a-like product with a higher nicotine con-
tent; and Vuse was only available with strength marked
as 4.8%, translating into 48 mg/ml.
The e-liquids in Gamucci and Blu contained propylene
glycol; all other products contained a combination of propyl-
ene glycol and vegetable glycerol, with no specification of
proportions.
Regarding the own brand EC, five participants used 1st
generation products with e-liquids containing 11–16 mg/ml
nicotine, four used 2nd generation products with e-liquids
containing 9–24 mg/ml nicotine and six used 3rd generation
products with e-liquids containing 6–12 mg/ml nicotine.
Participants used a range of flavours including mixtures, with
sweet (N = 5), fruit (N = 4) and tobacco (N = 4) flavours the
most common.
Statistical analysis
Differences between products were analysed using t tests with
Bonferroni correction for multiple comparisons to avoid false
positives due to multiple tests. A repeated measures ANOVA
was used to examine the overall effects of Time and EC brand
and any interactions between the two, on urges to smoke rated
over the 30 min testing period. Correlational analysis was
used to test for any associations between product characteris-
tics and nicotine delivery. Multiple regression was used to
assess the link between various product characteristics and
objective nicotine delivery and overall product ratings. PK
parameters (AUC0–> 30, Cmax, Tmax) were calculated using
PKSolver add-in for Excel (V2.0 (Zhang et al. 2010)).
Analyses were performed with SPSS v.22.
Results
Table 1 provides baseline characteristics of the sample.
Nicotine delivery and number of puffs
The number of puffs taken correlated negatively with AUC0–>
30 and Cmax (r = − 0.80, p = 0.018 and r = −0.60, p = 0.115,
respectively).
Refillable products generated higher nicotine levels than
cig-a-like products using similar e-liquids, despite being used
with fewer puffs. KangerTech and Innokin (20 mg/ml nico-
tine) were used with 16.8 puffs (SD = 5.3) and provided Cmax
(SD) and AUC0–> 30 (SD) of 11.8 (5.7) and 229 (77) while the
cig-a-like products other than Vuse (16–24 mg/ml nicotine)
were used with 20.4 puffs (SD = 5.6) and generated Cmax (SD)
and AUC0–> 30 (SD) of 9.5 (4.0) and 163 (63.4) (p = 0.006 for
puffs, p = 0.029 for Cmax and p = 0.001 for AUC0–> 30). Own
brand products which were mostly refillable, provided even
higher nicotine levels while using lower nicotine concentra-
tion e-liquids (see Table 2).
Effects on urges to smoke
Figure 1 shows the effect of different EC products on urges to
smoke.
In a repeated measures ANOVA (EC brand × Time), all EC
reduced urge to smoke at every time point compared to base-
line (all p’s ≤ 0.001). There was no overall effect of EC brand
nor an EC brand × Time interaction.
The tank product (KangerTech) generated a larger decrease
in craving at 5 min than other products, but after adjusting for
multiple comparisons, the difference was no longer signifi-
cant. The own brand EC had an effect that lasted longer than
the rest but when adjusted for multiple comparisons, this too
became non-significant.
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The ratings provided at the end of each session
corresponded with the momentary assessments during the
vaping session, with KangerTech perceived as providing the
greatest and fastest relief of urge to smoke (see Fig. 2), signif-
icantly different from Vype, Gamucci, Puritane and E-Lites
(adjusted p = 0.03 to p < 0.005).
Perception of nicotine delivery
The two advanced products (KangerTech and Innokin)
were perceived as delivering the most nicotine, signifi-
cantly different to Vype and Gamucci (adjusted p’s <
0.001) and to E-Lites (adjusted p = 0.028 and p =
0.056, respectively).
Products most often rated to be ‘just right’ in nicotine de-
livery were own brand (40%), followed by Vype (33%) and
Gamucci (33%) (see Fig. 3).
Throat hit
KangerTech and Innokin provided the strongest throat hit/
scratch, significantly more than Vype, Gammuci and Blu
(adjusted p < 0.02). Products most often rated to be ‘just right’
in throat hit were Puritane (44%) followed by own brand
(38%) and Gamucci (33%) (see Fig. 3).
Perception of vapour production
Own brand was rated as providing the most amount of vapour
but was not significantly different to other brands when ad-
justed for multiple comparisons. Puritane gave the least
amount of vapour and was significantly different to Innokin
and KangerTech (adjusted p < 0.05).
Products most often rated to be ‘just right’ in vapour pro-
duction were Vuse (50%), followed by own brand (44%) and
Gamucci and Innokin (40%) (see Fig. 3).
Other product characteristics: taste
Despite the fact that all products other than own brand used
tobacco flavoured e-liquids, significant differences emerged.
Blu received the most favourable rating while Vype received
the lowest rating, significantly below Blu, Gamucci, Puritane
and E-Lites (adjusted p < 0.03). Own brand, which used fla-
vours that participants selected themselves, was predictably
rated the highest (see Fig. 4).
Ease of draw
Vype was rated as having the hardest draw, significantly dif-
ferent from own brand, KangerTech, Gamucci and Elites (ad-
justed p < 0.05), and marginally from Blu and Vuse (adjusted
p = 0.05) (see Fig. 5). KangerTech had the easiest draw, sig-
nificantly different from Vype and Puritane (adjusted p =
0.02).
Products most often rated to be ‘just right’ in ease of draw
were own brand (73%), followed by Vuse and KangerTech
(53%).
Table 1 Baseline characteristics (N = 15)
Age, mean (SD) 36.3 (11.2)
Male 86.7%
Higher education 60%
Cigarettes smoked per day before starting EC
use, mean (SD)
13.4 (7.6)
FTCD before EC use, mean (SD) 3.8 (2.5)
EC cartridges used per day, mean (SD)* 1.4 (1.4)
Ml e-liquid used per day, mean (SD)** 3.7 (1.6)
No. months using EC daily, mean (SD) 19.3 (16.7)
Days EC used in last week, mean (SD) 7 (0)
Cigarettes smoked per week currently, mean (SD)*** 11.2 (14.2)
*N = 6, **N = 8, data missing for one participant, ***N = 11
Table 2 Nicotine delivery and
number of puffs from different
EC products (N = 15)
Product Number of puffs (SD) Cmax (SD) Tmax (range) AUC0–> 30 (SD)
Own brand (6–16 mg/ml) 18 (5) 12.6 (12) 6 (2–30) 234 (197)
Blu (18 mg/ml) 20 (6) 8.4 (6) 6 (4–30) 167 (105)
Vype (16.8 mg/ml) 22 (6) 8.2 (5) 6 (4–30) 159 (88)
Puritane (20 mg/ml) 22 (10) 6.9 (5) 6 (4–30) 137 (59)
Vuse (48 mg/ml) 19 (4) 14.0 (10) 4 (2–10) 254 (113)
Gamucci (16 mg/ml) 19 (5) 10.0 (6) 6 (2–8) 185 (75)
E-Lites (24 mg/ml) 19 (6) 8.8 (6) 6 (4–30) 189 (124)
KangerTech (20 mg/ml) 17 (6) 9.8 (6) 6 (2–30) 201 (106)
Innokin (20 mg/ml) 17 (6) 11.3 (7) 6 (4–30) 230 (107)
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Mouthpiece comfort
Own brand EC was rated as having the most comfortable
mouthpiece, significantly different from E-Lites, Puritane
and Gamucci (all adjusted p’s < 0.05) (see Fig. 5).
Of the remaining brands, Blu was rated as having the most
comfortable mouthpiece, significantly better than Gammuci
and E-Lites (adjusted p < 0.05).
Overall ratings: pleasantness, likelihood
of recommending the product to friends
and retrospective ranking for overall liking
Own brand was rated the highest on all ratings. Among the
eight other brands, KangerTech was rated the most pleasant,
significantly different from Vype (adjusted p = 0.039) (see
Fig. 6). KangerTech was also most likely to be recommended
to friends (significantly better rating than Vype and Puritane,
adjusted p < 0.001 and p < 0.05, respectively). Blu and
Innokin also received a better rating than Vype (adjusted
p < 0.05 and p = 0.05, respectively) and Blu received a better
rating than Puritane (adjusted p < 0.05) (see Fig. 6).
In retrospective overall liking, after own brand, Blu and
KangerTech were the most liked brands, rated significantly
higher than Puritane, Vype, E-Lites, Gamucci and Vuse (ad-
justed p < 0.03). Innokin was next (Fig. 7).
As all products were tested in the same order, we checked
for an order effect for all three of the overall ratings. None was
significant (p = 0.59, p = 0.54 and p = 0.31 for pleasantness,
recommending products to friends, and the final ranking,
respectively).
Relationships between different product features
Of the three overall product ratings, we considered
‘recommending product to friends’ as the most relevant. The
‘pleasantness’ ratings concerned only one aspect of the prod-
uct effects and the retrospective ratings relied on recalling
experiences several months old.
As this was to evaluate the importance of different product
characteristics on the first impressions, own brand was not
included.
Table 3 shows correlations of different product features
with nicotine del ivery (AUC0–> 30) and with the





























Fig. 1 Ratings of urges to smoke
when using different EC products












Urge relief 1=not at all, 10=extremely Speed of relief 1=very slowly 10=extremely fast
Fig. 2 Ratings of effects of
different EC brands on urge to
smoke
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Objective nicotine delivery correlated significantly only
with the rating of throat hit. (This was despite the fact that as
mentioned in the ‘Methods’ section, questions regarding va-
pour and throat hit were included at a later date and so only 9
of the 15 participants completed them for all the study prod-
ucts). Recommending products to friends correlated with
mouthpiece comfort, urge relief, vapour production and con-
sidering the degree of draw resistance to be ‘just right’.
Regarding other relationships between the individual
variables:
Number of puffs which correlated negatively with nicotine
delivery, also correlated negatively with vapour production
(r = − 0.90, p = 0.003) and with throat hit (r = − 0.70, p =
0.054).
Like the objective nicotine delivery, perceived nicotine de-
livery also correlated significantly only with throat hit (r =
0.89, p = 0.003).
We entered the following product characteristics: ease of
draw, mouthpiece comfort, vapour volume, taste, throat hit/
scratch and perception of nicotine delivery into three
regression models (backward stepwise regression) to de-
termine how they relate to overall ratings of product
pleasantness, the likelihood of recommending the prod-
uct to a friend and the retrospective product ranking.
The results need to be interpreted with caution because
of the small sample size (N = 8).
For the retrospective ranking, significant univariate
correlates included urge relief and mouthpiece comfort
but the multivariate model retained mouthpiece comfort
only (b = 0.949, p < 0.001). For ratings of overall pleas-
antness, mouthpiece comfort, taste, throat hit/scratch and
perception of nicotine delivery were retained in the final
model, (b = 1.09, p = 0.015; b = 0.48, p = 0.044; b = 1.62,
p = 0.028 and b = − 1.55, p = 0.043, respectively.). For
recommending products to a friend, the final model
retained mouthpiece comfort (b = 0.65, p = 0.002), throat
hit/scratch (b = 0.26, p = 0.057); and ease of draw being
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Fig. 3 Perceptions of nicotine
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Fig. 4 Ratings of how much
participants liked the product taste
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Discussion
The study generated a range of novel findings. Before we
discuss their implications, it needs to be acknowledged that
the study had several limitations.
The sample was relatively small, but of the usual size for
these types of studies that require an intensive participant in-
volvement over a protracted period of time. The main draw-
back of a limited sample size is that the study could be ex-
pected to detect only strong trends. Negative findings need to
be interpreted with caution, but a number of findings reached
statistical significance. The participants were not a homoge-
nous group in terms of their smoking (both pre- and post-dual
use) and their vaping behaviour (e.g. in terms of which own
brand they used and how much they used it). This means that
we could only detect general effects that are applicable across
a range of smokers with different needs. Most participants
were male and the findings may be less generalizable to fe-
male vapers. We did not check the accuracy of the labelling of
nicotine content provided by the manufacturers, but manufac-
turer labelling in western markets tends to be accurate
(Beauval et al. 2017; Etter and Bugey 2017; Goniewicz
et al. 2014). There is some indication that the proportion of
PG and VG in e-liquids can affect consumer reactions (Etter
2016) but the products we tested did not provide sufficient
information to evaluate this. The finding that own EC product
was rated as superior to others could be influenced by the fact
that all the experimental products had tobacco flavour while
most participants used other flavours in their own product. All
participants reported abstinence on the days of testing, but
checking baseline blood results showed that one participant
had somewhat elevated nicotine levels on two occasions
(14.4 ng/ml and 17 mg/ml). This is likely to be due to having
vaped late at night (study sessions took place between 7:30
and 9:30 am) but it would have been better to require 12-h
rather than overnight abstinence. It is also important to note
that different EC products were used on only one occasion.
The results could be different if the products were used over a
prolonged period of time. Our purpose however was to deter-
mine which product features influence the first impressions.
Puffing frequency and nicotine intake
Puffing frequency correlated negatively with nicotine intake.
This suggests that participants were making an effort to obtain
more nicotine from low-delivery products. The opposite pro-
cess, i.e. reducing puffing to avoid aversive effects from high
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Fig. 6 Rating of pleasantness and
likelihood of recommending EC
brand to friends
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puffs generate more vapour and more throat sensation and
both of these variables correlated positively rather than nega-
tively with recommending products to friends and so were
more likely to be sought rather than avoided. As reported
previously (Hajek et al. 2017), in a subsample of participants
who were dual users, more puffs were taken from EC products
than from cigarettes; and cigarettes delivered more nicotine
than EC products (values for own cigarette were 14 puffs
(SD = 4.5); Cmax (SD) 17.9 (16); AUC0–> 30 (SD) 315 (155)).
If we assume that vapers increased their puffing rate to
try to compensate for low nicotine delivery, it is important
to note that this was not successful. Individual vapers
were not achieving similar nicotine delivery from different
products despite varying their puffing rate. This corre-
sponds with a previous finding showing that novice vapers
can learn to increase their nicotine intake from vaping, but
the improvements are only modest (Hajek et al. 2014b).
Conventional cigarettes seem to allow a much more flex-
ible titration of nicotine delivery via, e.g. changes in the
rate and depth of inhalations (Jarvis et al. 2001). Our
finding suggests that existing EC products provide only
a limited scope for varying nicotine intake by varying
vaping topography.
Cig-a-likes versus refillable products
Refillable EC products delivered more nicotine than cig-a-like
products with similar nicotine content and received higher
ratings on urge relief, perceived nicotine delivery, throat hit
and vapour volume. In overall ratings however, they were
joined by Blu. Blu received the highest ratings for mouthpiece
comfort and for taste.
It remains unclear whether the ‘first impression’ advan-
tages related to sensory variables remain in force after extend-
ed use. Surveys cited in the introduction suggest that over
recent years, EC novices usually started on cig-a-like products
but that long-term vapers use almost exclusively refillable
products. It is possible that conditioned and sensory stimuli
override nicotine feedback early on, but with prolonged use,
vapers gravitate to products with higher nicotine delivery.
Other explanations are possible, however. Vapers may find
refillable products preferable and move over to them because
they allow a much wider choice of flavours which for many
vapers is an important consideration (Farsalinos et al. 2013);
because they generate higher vapour volume which was relat-
ed positively to overall product rating; and/or because for










1=Product liked the least; 9=Product liked  the most
Fig. 7 Overall rankings of EC
brands
Table 3 Correlations between
product characteristics and
objective nicotine delivery and
the likelihood of recommending
products to friends
Product characteristic Nicotine delivery (AUC0–> 30) Recommending products to friends
Urge relief 0.35 0.80 (p = 0.02)
Perception of nicotine delivery 0.67 0.69
Throat hit 0.72 (p = 0.04) 0.54
Vapour production 0.67 0.82 (p = 0.01)
Taste − 0.11 0.31
Ease of draw (‘just right’) 0.65 0.77 (p = 0.03)
Mouthpiece comfort 0.44 0.84 (p < 0.01)
Nicotine delivery (AUC0–> 30) – 0.65
The correlation is not significant unless p value is provided
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advanced EC, tank products are cheaper to use than cig-a-
likes.
Effect of vaping on craving reduction, nicotine
feedback and ‘throat hit’
All ECs significantly reduced urge to smoke (craving) after
overnight abstinence. Previous research showed that even
nicotine-free EC can have this effect (Dawkins et al. 2012;
Przulj et al. 2016). The effects of conditioned sensory-motor
cues and possibly also effects of distraction can be initially as
important as effects of nicotine, but over time smokers seem to
habituate to the signals that are no longer reinforced so they
stop eliciting the initial response (McRobbie et al. 2016). It is
possible that a similar mechanism applies to vapers.
When considering the substantial craving reduction that
occurred largely independent of nicotine intake, it is important
to note that all EC delivered some nicotine (Cmax 7–14 ng/ml)
and did this at a similar speed. Within the observed nicotine
delivery range, central nicotine effects may be similar, or pro-
vide only limited experiential signals and smokers are instead
clued by various conditioned sensory stimuli. Data we collect-
ed can throw some light on which sensory signals are relevant.
The only variable that correlated significantly with per-
ceived nicotine delivery was the ‘throat hit’. Throat sensations
are known to be important to vapers (Etter 2016) and they also
play an important role in smoking (Rose 2006). A linear de-
crease in craving for cigarettes has been reported in response
to anaesthesia of the mouth, pharynx and tracheobronchial
airways (Rose et al. 1984). Our results suggest that the feed-
back from the respiratory tract is proportional to the actual
nicotine intake. The throat hit correlated significantly not only
with the perception of howmuch nicotine is being inhaled, but
also with the actual nicotine intake.
Mechanical product characteristics
Two mechanical features of EC products that we considered
marginal turned out to be important. Draw resistance, which
depends on the aperture of the mouthpiece, and the feel of the
mouthpiece affected strongly overall product ratings. ECman-
ufacturers should note that these two mechanical features that
are easy to adjust may play a major role in the initial product
appraisal.
Conclusions
A range of EC products provide a significant reduction of
urges to smoke acutely. Refillable products deliver higher nic-
otine levels and generate better consumer ratings in general
than cig-a-likes with similar nicotine content. Lower nicotine
delivery is associated with more frequent puffing. Sensations
in the throat (‘throat hit’) reflect nicotine delivery and guide
vapers’ perception of it. The first impressions of EC products
are guided largely by sensory signals, of which draw resis-
tance is particularly noteworthy.
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